Sheng Ruo Fan, Zeng Meng Su, Ji Yuan, Yang Li, Chen Cai Zhong, Rao Sheng Xiang
Department of Radiology, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Xuhui District, 200032, Shanghai, China.
Shanghai Institute of Medical Imaging, Shanghai, China.
Abdom Imaging. 2015 Oct;40(8):3062-9. doi: 10.1007/s00261-015-0536-3.
The objective of this study is to compare MR imaging features of small hepatocellular carcinoma (HCC) (≤ 2 cm) in normal, fibrotic, and cirrhotic liver.
A total of 215 patients with 235 pathologically proven sHCC were retrospectively analyzed. Patients were classified into three groups according to the patients' liver condition: patients with normal liver (F0, group 1), fibrosis without cirrhosis (F1-3, group 2), and cirrhosis (F4, group 3). The morphological and MR signal features on T1, T2-weighted, dynamic enhanced, and diffusion-weighted imaging were evaluated and compared.
There were 10, 38, and 167 patients in group 1, 2, and 3, respectively. Patients with normal liver were older than those with fibrosis or cirrhosis (P = 0.0086), and tumors in the normal liver were larger than those in the fibrotic or cirrhotic liver (P = 0.0407). No statistical differences were found among groups in signals on T2-weighted images (P = 0.163), signals on each phase after contrast (P = 0.269, 0.893, and 0.259, respectively), enhancement patterns (P = 0.753), ADC values (P = 0.760), as well as the presence of capsule-like enhancement (P = 0.953), mosaic pattern (P = 0.572), fat content (P = 0.222), iron sparing (P = 1.000), hemorrhage (P = 0.181), and venous invasion (P = 0.175). Both signal-to-noise ratios (SNR) (χ (2) = 2.045, P = 0.132) and lesion-to-liver contrast-to-noise ratios (CNR) (χ (2) = 0.438, P = 0.646) were not different as well. But confusing features of iso/hypointensity on T2-weighted imaging (n = 11, 6.0%) and progressive enhancement pattern (n = 2, 1.1%) were exclusively found in the cirrhosis background, and hypovascular tumors with iso/hypointensity on arterial phase were only seen in the fibrosis (n = 5, 11.9%) and cirrhosis groups (n = 10, 5.5%).
MR features of sHCC were similar among patients with normal, fibrotic, and cirrhotic livers.
本研究的目的是比较正常肝脏、纤维化肝脏和肝硬化肝脏中微小肝细胞癌(HCC)(≤2 cm)的磁共振成像(MR)特征。
回顾性分析215例有235个经病理证实的小肝癌患者。根据患者肝脏状况将患者分为三组:正常肝脏患者(F0,第1组)、无肝硬化的纤维化患者(F1 - 3,第2组)和肝硬化患者(F4,第3组)。评估并比较T1加权、T2加权、动态增强和扩散加权成像上的形态学和MR信号特征。
第1组、第2组和第3组分别有10例、38例和16例患者。正常肝脏患者比纤维化或肝硬化患者年龄大(P = 0.0086),正常肝脏中的肿瘤比纤维化或肝硬化肝脏中的肿瘤大(P = 0.0407)。在T2加权图像上的信号(P = 0.163)、对比剂注射后各期的信号(分别为P = 0.269、0.893和0.259)、强化方式(P = 0.753)、表观扩散系数(ADC)值(P = 0.760)以及包膜样强化(P = 0.953)、镶嵌样表现(P = 0.572)、脂肪含量(P = 0.222)、铁沉积减少(P = 1.000)、出血(P = 0.181)和静脉侵犯(P = 0.175)方面,各组之间均未发现统计学差异。信噪比(SNR)(χ(2)=2.045,P = 0.132)和病变与肝脏的对比噪声比(CNR)(χ(2)=0.438,P = 0.646)也无差异。但T2加权成像上等/低信号的混淆特征(n = 11,6.0%)和渐进性强化方式(n = 2,1.1%)仅在肝硬化背景中发现,动脉期等/低信号的乏血供肿瘤仅在纤维化组(n = 5,11.9%)和肝硬化组(n = 10,5.5%)中出现。
正常肝脏、纤维化肝脏和肝硬化肝脏患者中小肝癌的MR特征相似。